Melphalan waxa ansixisay FDA sidii daawaynta beerka hageysa ee uveal melanoma

Melphalan waxa ansixisay FDA sidii daawaynta beerka hageysa ee uveal melanoma
HEPZATO KIT (melphalan loogu talagalay Injection/Hepatic Delivery System, Delcath Systems, Inc.) waxaa ansixiyay Maamulka Cuntada iyo Dawooyinka sida daawaynta beerka haga ee bukaanada qaangaarka ah ee leh melanoma uveal kuwaas oo leh cagaarshow cagaarshow aan la daboolin oo saameeya in ka yar 50% beerka oo aan lahayn cudur kabaxsan, ama cudur kabaxsan oo ku kooban sambabada, lafaha, qanjidhada, ama unugyada subcutaneous waxaana lagu daweyn karaa shucaac ama dib-u-saarid.

La qaybso Post this

Noofambar 2023: Maamulka Cunnada iyo Dawooyinka ayaa ansixiyay HEPZATO KIT (melphalan for Injection/Hepatic Delivery System, Delcath Systems, Inc.) sida daawaynta beerka haga ee bukaanada qaangaarka ah ee qaba melanoma uveal kuwaas oo leh cagaarshow cagaarshow aan la daboolin oo saameeya wax ka yar 50% beerka iyo ma jiro cudur kabaxsan, ama cudur kabaxsan oo ku xaddidan sambabada, lafaha, qanjidhada, ama unugyada subcutaneous oo waxay noqon kartaa

Daraasadda FOCUS (NCT02678572), 91 qof oo qaba melanoma uveal melanoma iyo metastases beerka oo aan la saari karin ayaa ka qayb qaatay hal gacan, tijaabo sumad furan si loo arko sida ugu wanaagsan ee daaweyntu u shaqeyso. Haddii qaybta ugu khatarta badan ee melanoma ee uveal melanoma ay ka timaaddo beerka oo cudurka ka baxsan beerka lagu daweyn karo daaweynta shucaaca ama qaliinka, markaa cudur ka baxsan beerka ayaa laga heli karaa sambabada, qanjidhada qanjidhada, lafaha, ama maqaarka hoostiisa. . Sababaha muhiimka ah ee aan loogu qalmin ayaa ah inuu ku dhaco metastases ugu yaraan 50% parenchyma beerka, oo leh Child-Pugh Class B ama C cirrhosis, ama cagaarshow B ama C.

Siyaabaha ugu muhiimsan ee lagu cabbiro sida wanaagsan ee wax u shaqeeyeen waxay ahaayeen heerka jawaabta ujeeddada (ORR) iyo muddada jawaabta (DoR), kuwaas oo ay go'aamiyeen guddi dhexdhexaadin ah oo cadaalad ah oo isticmaalaya RECIST v1.1. Dhexdhexaadka DoR wuxuu ahaa 14 bilood (95% CI: 8.3, 17.7), ORR wuxuu ahaa 36.3% (95% CI: 26.4, 47).

Melphalan (HEPZATO) waxaa lagu shubaa halbowlaha beerka beerka 6 ilaa 8 asbuuc kasta ugu badnaan 6 faleebo iyadoo la isticmaalayo Nidaamka Bixinta Cagaarshowga (HDS), qayb ka mid ah qalabka. Iyada oo ku saleysan miisaanka jirka ee saxda ah, qiyaasta melphalan ee la soo jeediyay waa 3 mg/kg, oo leh qiyaasta ugu badan ee 220 mg hal daawaynta.

Waxaa jira Digniin Sanduuqan oo ku saabsan cawaaqib-xumo halis ah, sida dhiig-baxa, dhaawaca beerka, iyo dhacdooyinka thromboembolic, oo ku jira agabka qoraya qalabka HEPZATO. Digniin sanduuq ah oo ku saabsan myelosuppression iyo suurtagalnimada infekshannada halista ah, dhiig-baxa, ama dhiig-yaraanta calaamaduhu waxay sidoo kale ku jirtaa walxaha qorida.

Sababo la xiriira suurtagalnimada cawaaqibka habraacyada halista ah sida dhacdooyinka thromboembolic, dhaawaca hepatocellular, iyo dhiig-baxa, HEPZATO KIT waxaa lagu heli karaa oo keliya iyada oo loo marayo barnaamijka xaddidan ee hoos yimaada Qiimaynta Khatarta KIT ee HEPZATO iyo Xeeladda Yaraynta.

Thrombocytopenia, daal, dhiig-yaraan, lallabbo, xanuunka murqaha, leukopenia, calool xanuun, neutropenia, matag, korodhka alanine aminotransferase, thromboplastin qayb firfircoon oo dheeraad ah, kordhinta aminotransferase aspartate, fosfatase dhiig oo kordhay, iyo dyspnea ayaa ahaa kuwa ugu caansan (20%) falcelinta xun ama cilladaha shaybaarka.

HEPZATO iyo KIT-KA HEPZATO waa ka mamnuuc bukaanada qaba metastases-ka firfircoon ee intracranial ama nabarada maskaxda ee u nugul inay dhiig baxaan; beerka oo shaqadiisa gabay, hypertension portal, ama kala duwanaansho la og yahay oo halis ugu jira dhiigbax; qalliin ama daawaynta beerka ee 4 toddobaad ee la soo dhaafay; xinjirowga lidka ku ah aan la sixi karin, awood la'aanta in si badbaado leh loo maro suuxdinta guud, oo ay ku jiraan xaaladaha wadnaha ee firfircoon oo ay ku jiraan, laakiin aan ku xaddidnayn, cilladaha wadnaha ee aan degganayn (angina aan degganayn ama daran ama wadnaxanuun myocardial), ka sii dara ama bilawga cusub ee wadne-gabka wadnaha, arrhythmias weyn, ama cudur valvular daran ; taariikhda xasaasiyadda ama xasaasiyad la yaqaan ee melphalan; taariikhda xasaasiyadda ama dareenka kacsanaanta la og yahay ee qayb ama walxo lagu isticmaalo gudaha HEPZATO KIT oo ay ku jirto taariikhda xasaasiyadda cinjirka dabiiciga ah; taariikhda xasaasiyadda ama xasaasiyadda heparin ama joogitaanka heparin-induced thrombocytopenia (HIT); iyo taariikhda falcelinta xasaasiyadda daran ee ka soo horjeedda iodinated ee aan la xakameynin daawaynta hore ee antihistamines iyo steroids.

Eeg macluumaadka qorista oo dhammaystiran ee KITKA HEPZATO.

Ku soo Dhawo Wargeyskayaga

Hel wax cusub oo waligaa ha ka maqnaan blog ka Cancerfax

Inbadan Oo La Baadho

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS
Kansarka

Lutetium Lu 177 dotatate waxa ansixisay USFDA bukaanada carruurta 12 sano iyo ka weyn ee GEP-NETS

Lutetium Lu 177 dotatate, oo ah daawayn hor leh, ayaa dhawaan ogolaansho ka heshay Maamulka Cunnada iyo Dawooyinka ee Maraykanka (FDA) ee bukaanada carruurta, taas oo calaamad u ah guul muhiim ah oo ku saabsan kansarka carruurta. Oggolaanshahani waxa uu u taagan yahay iftiin rajo u ah carruurta la dagaallamaysa burooyinka neuroendocrine (NETs), oo ah nooc naadir ah laakiin adag oo kansar ah kaas oo inta badan caddeeya u adkaysiga daaweynta caadiga ah.

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG
Kansarka kaadiheysta

Nogapendekin alfa inbakicept-pmln waxa u ansixisay USFDA kansarka kaadiheysta ee aan muruqa ahayn ee aan ka jawaabin BCG

"Nogapendekin Alfa Inbakicept-PMLN, immunotherapy novel, waxay muujinaysaa ballanqaad daawaynta kansarka kaadiheysta marka lagu daro daawaynta BCG. Habkan cusubi waxa uu bartilmaameedsanayaa calaamado gaar ah oo kansar ah iyada oo la xoojinayo jawaabta habka difaaca jidhka, iyada oo kor u qaadeysa waxtarka daaweynta dhaqameed sida BCG. Tijaabooyin caafimaad ayaa muujinaya natiijooyin dhiirigelin leh, oo muujinaya natiijooyinka bukaan-socodka oo soo hagaagay iyo horumarka suurtagalka ah ee maareynta kansarka kaadiheysta. Is-waafajinta ka dhexeeya Nogapendekin Alfa Inbakicept-PMLN iyo BCG waxay ku bishaaraynaysaa waa cusub oo daawaynta kansarka kaadiheysta."

Ma u baahan tahay caawimaad? Kooxdayadu waxay diyaar u yihiin inay ku caawiyaan.

Waxaan u rajeynaynaa caafimaad deg-deg ah mid aad jeceshahay iyo mid kuu dhow.

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton